Pharmaceutical Intermediates Market Estimated to Generate a Revenue of US$ 52.6 Bn By 2030

According to Precedence Research, the global pharmaceutical intermediates market size is forecasted to reach US$ 52.6 billion by 2030 from US$ 29 billion in 2021, by growing at a lucrative CAGR of 6.3% between 2021 and 2030.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1356

The global pharmaceutical intermediates market is primarily driven by the rising burden of chronic diseases and growing geriatric population across the globe. The growing prevalence of chronic diseases such as cancer, leukemia, lymphoma, diabetes, and muscular degeneration are the major factors that propel the demand for the development of various drugs for the treatment. The growing geriatric population is fueling the demand for the drugs for the treatment of age related medical conditions across the globe. Further, the rapid growth of the biotechnology industry is fostering the demand for the pharmaceutical intermediates for the manufacturing of wider range of medicines. The rising adoption of biopharmaceutical products among the global population due to its improved effectiveness and efficiency in the treatment of chronic ailments is fueling the growth of the global pharmaceutical intermediates market.

According to the International Agency for Research on Cancer, in 2020, around 19.3 million new cancer cases and 10 million cancer deaths were reported across the globe. Further, the geriatric population is expected to reach closer to 2 million by the year 2050. These numbers are the indicators of the increasing global demand for the various drugs across the globe, during the forecast period.

The rising production of the active pharmaceutical ingredients is another driving force of the global pharmaceutical intermediates market. The growing trend of high-tech therapeutics coupled with the advanced delivery systems and development of personalized and customized drugs is boosting the demand for the active pharmaceutical ingredients across the globe. The pharmaceutical intermediates are used for the production of these APIs, and hence the rising production of APIs is driving the global pharmaceutical intermediates market.

The high costs associated with the acquisition of the biopharmaceutical drugs is a major factors that may indirectly impact the market growth in an adverse way. Moreover, high capital investments involved in the production of APIs is a major restraining factor that may hamper the market growth.

The introduction of latest technologies in the production of various medicines in the pharmaceutical industry and rising investments in the research activities are expected to provide various growth aspects to the market players in the upcoming future.

North America dominated the global pharmaceutical intermediates market in 2020. This can be attributed to the increased investments on the development of biopharmaceutical industry. Moreover, the presence of numerous biotechnology companies and various CMOs and CROs are significantly contributing towards augmenting the demand for the pharmaceutical intermediates in the region. Further, regulatory bodies like FDA of US are ensuring standardization and good manufacturing practices of the companies involved that improves the credibility of the companies.

Asia Pacific is estimated to be the most opportunistic market owing to the increasing government expenditure on the development of pharmaceutical intermediate sector and development of sophisticated healthcare infrastructure. For instance,the Department of Pharmaceuticals prioritizes a list of 56 APIs under Make-in-India initiative. Further, China is the biggest importer of the APIs across the globe and hence, the demand for the pharmaceutical intermediates is high in China. Moreover, development of favorable foreign policies by the government to attract FDIs is expected to boost the market growth in this region.

Based on the product, the bulk drug intermediates segment accounted for around 60% of the market share in 2020. The growing demand and production of APIs for the manufacturing of wide variety of drugs is boosting the growth of the bulk drug intermediate segment. The custom intermediates segment is projected to witness strong growth during the forecast period.

Based on the application, the anti-cancer drug segment is estimated to be the fastest-growing segment during the forecast period owing to the rising prevalence of various cancers such as breast cancer, lungs cancer, and colorectal cancer among the global population. The analgesics segment hit over 30% of market share in 2020.

Based on the end user, the CMOs/CROs dominated the market in 2020. The rapid growth of the contract manufacturing organizations and contract research organization in the developing and developed regions has significantly boosted the demand for the pharmaceutical intermediates for manufacturing vast variety of drugs and for the research purposes. The research laboratories segment is anticipated to witness fastest growth over the forecast period.

Report Scope of the Pharmaceutical Intermediates Market

Report Highlights Details
Market Size USD 52.6 Billion by 2030
Growth Rate CAGR of 6.3% from 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030

Competitive Intelligence

The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.

Some of the prominent players in the global pharmaceutical intermediates market are listed as below:

  • Aceto Corporation
  • BASF SE
  • Chiracon GmbH
  • Yin-sheng Bio-tech Co. Ltd.
  • Dishman Group
  • Green Vision Life Sciences
  • Midas Pharma GmbH
  • Sanofi SAIS
  • Vertellus Holdings LLC.
  • Lonza Group

Segments Covered in the Report

By Product

  • Chemical Intermediates
  • Bulk Drug Intermediates
  • Custom Intermediates

By Application

  • Analgesics
  • Ant-inflammatory Drug
  • Cardiovascular Drugs
  • Anti-Diabetic Drugs
  • Anti-Cancer Drugs
  • Others

By End User

  • Biotech & Pharma Companies
  • Research Laboratory
  • CMO/CRO

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pharmaceutical Intermediates Market 

5.1. COVID-19 Landscape: Pharmaceutical Intermediates Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pharmaceutical Intermediates Market, By Product

8.1. Pharmaceutical Intermediates Market, by Product Type, 2021-2030

8.1.1. Chemical Intermediates

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Bulk Drug Intermediates

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Custom Intermediates

8.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Pharmaceutical Intermediates Market, By Application

9.1. Pharmaceutical Intermediates Market, by Application, 2021-2030

9.1.1. Analgesics

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Ant-inflammatory Drug

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Cardiovascular Drugs

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Anti-Cancer Drugs

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Anti-Diabetic Drugs

9.1.5.1. Market Revenue and Forecast (2019-2030)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Pharmaceutical Intermediates Market, By End User 

10.1. Pharmaceutical Intermediates Market, by End User, 2021-2030

10.1.1. Biotech & Pharma Companies

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Research Laboratory

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. CMO/CRO

10.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Pharmaceutical Intermediates Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)

Chapter 12. Company Profiles

12.1. Aceto Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. BASF SE

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Chiracon GmbH

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Yin-sheng Bio-tech Co. Ltd.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Dishman Group

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Green Vision Life Sciences

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Midas Pharma GmbH

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Sanofi SAIS

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Vertellus Holdings LLC.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Lonza Group

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms0

Why should you invest in this report?

If you are aiming to enter the global pharmaceutical intermediates market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for pharmaceutical intermediates are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable. 

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1356

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.